First Wave BioPharma (FWBI) Short Interest Ratio & Short Volume → Invest in the 'Trojan Horse' of Alzheimer's Treatment (From Behind the Markets) (Ad) Free FWBI Stock Alerts $2.96 +0.13 (+4.59%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media First Wave BioPharma Short Interest DataCurrent Short Volume46,600 sharesPrevious Short Volume40,000 sharesChange Vs. Previous Month+16.50%Dollar Volume Sold Short$123,024.00Short Interest Ratio / Days to Cover0.5Last Record DateApril 30, 2024Outstanding Shares2,030,000 sharesFloat Size1,950,000 sharesShort Percent of Float2.39%Today's Trading Volume56,362 sharesAverage Trading Volume212,943 sharesToday's Volume Vs. Average26% Short Selling First Wave BioPharma ? Sign up to receive the latest short interest report for First Wave BioPharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatFWBI Short Interest Over TimeFWBI Days to Cover Over TimeFWBI Percentage of Float Shorted Over Time Ad Paradigm PressDems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. First Wave BioPharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202446,600 shares $123,024.00 +16.5%2.4%0.5 $2.64 4/15/202440,000 shares $130,800.00 -27.3%2.1%0.3 $3.27 3/31/202455,000 shares $240,900.00 +295.7%3.0%0.4 $4.38 3/15/202413,900 shares $65,886.00 -54.1%0.9%0 $4.74 2/29/202430,300 shares $239,067.00 -14.4%1.9%0 $7.89 2/15/202435,400 shares $182,310.00 -80.0%5.8%0.1 $5.15 Get the Latest News and Ratings for FWBI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for First Wave BioPharma and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024176,600 shares $935,980.00 +39.7%28.7%0.3 $5.30 1/15/2024126,400 shares $511,920.00 -65.6%19.3%0.2 $4.05 12/31/2023367,800 shares $1.54 million +2,914.8%54.5%0.6 $4.20 12/15/202312,200 shares $53,899.60 -96.2%1.8%0 $4.42 11/30/2023317,300 shares $87,194.04 +45.9%2.4%0.1 $0.27 11/15/2023217,500 shares $58,551.00 +52.7%1.6%0.1 $0.27 10/31/2023142,400 shares $41,110.88 +37.6%1.1%0 $0.29 10/15/2023103,500 shares $36,276.75 -36.2%0.8%0 $0.35 9/30/2023162,100 shares $47,009.00 -45.6%1.2%0 $0.29 9/15/2023297,700 shares $130,988.00 +1,253.2%4.2%0.1 $0.44 8/31/202322,000 shares $6,820.00 -37.7%0.3%0 $0.31 8/15/202335,300 shares $14,942.49 -22.4%0.5%0 $0.42 7/31/202345,500 shares $24,902.15 -91.2%1.1%0 $0.55 7/15/2023514,200 shares $488,490.00 +143.1%12.2%0.3 $0.95 6/30/2023211,500 shares $338,400.00 -79.9%5.0%0.1 $1.60 6/15/20231,050,000 shares $2.00 million +1,701.0%24.9%0.7 $1.90 5/31/202358,300 shares $108,438.00 +4.7%3.2%0.6 $1.86 5/15/202355,700 shares $151,504.00 +19.8%3.1%0.7 $2.72 4/30/202346,500 shares $135,315.00 -33.6%3.1%0.5 $2.91 4/15/202370,000 shares $184,800.00 +31.6%4.7%0.2 $2.64 3/31/202353,200 shares $142,576.00 -27.4%3.7%0.1 $2.68 3/15/202373,300 shares $218,434.00 -4.4%4.7%0.1 $2.98 2/28/202376,700 shares $273,052.00 -19.3%9.3%0.2 $3.56 2/15/202395,000 shares $360,050.00 -30.9%11.5%0.2 $3.79 1/31/2023137,500 shares $745,250.00 +500.4%16.6%0.3 $5.42 1/15/202322,900 shares $14,882.71 -62.5%2.8%0.1 $0.65 12/30/202261,000 shares $53,411.60 -65.0%1.1%0.1 $0.88 12/15/2022174,100 shares $104,477.41 -52.7%3.0%0.2 $0.60 11/30/2022368,400 shares $305,772.00 -31.1%6.4%0.5 $0.83 11/15/2022534,500 shares $475,865.35 +105.3%9.3%0.4 $0.89 10/31/2022260,400 shares $286,440.00 +90.1%18.9%0.2 $1.10 10/15/2022137,000 shares $153,440.00 -64.4%9.9%0.2 $1.12 9/30/2022384,300 shares $568,764.00 +176.5%27.9%0.4 $1.48 9/15/2022139,000 shares $283,560.00 +160.3%10.1%0.2 $2.04Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. FWBI Short Interest - Frequently Asked Questions What is First Wave BioPharma's current short interest? Short interest is the volume of First Wave BioPharma shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 46,600 shares of FWBI short. 2.39% of First Wave BioPharma's shares are currently sold short. Learn More on First Wave BioPharma's current short interest. What is a good short interest percentage for First Wave BioPharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.39% of First Wave BioPharma's floating shares are currently sold short. Is First Wave BioPharma's short interest increasing or decreasing? First Wave BioPharma saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 46,600 shares, an increase of 16.5% from the previous total of 40,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is First Wave BioPharma's float size? First Wave BioPharma currently has issued a total of 2,030,000 shares. Some of First Wave BioPharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. First Wave BioPharma currently has a public float of 1,950,000 shares. How does First Wave BioPharma's short interest compare to its competitors? 2.39% of First Wave BioPharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to First Wave BioPharma: Xenetic Biosciences Inc (0.50%), Enveric Biosciences, Inc. (1.07%), Lixte Biotechnology Holdings, Inc. (1.31%), Kineta, Inc. (1.96%), Processa Pharmaceuticals, Inc. (24.82%), Adial Pharmaceuticals, Inc. (4.42%), Lipella Pharmaceuticals Inc. (1.05%), Hoth Therapeutics, Inc. (2.73%), Ainos, Inc. (2.12%), Genprex, Inc. (2.46%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short First Wave BioPharma stock? Short selling FWBI is an investing strategy that aims to generate trading profit from First Wave BioPharma as its price is falling. FWBI shares are trading up $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against First Wave BioPharma? A short squeeze for First Wave BioPharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FWBI, which in turn drives the price of the stock up even further. How often is First Wave BioPharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FWBI, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: XBIO Short Squeeze ENVB Short Squeeze LIXT Short Squeeze KA Short Squeeze PCSA Short Squeeze ADIL Short Squeeze LIPO Short Squeeze HOTH Short Squeeze AIMD Short Squeeze GNPX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FWBI) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsObama’s Forever Term [exposed]Porter & CompanyGold Set to EXPLODE!Gold Safe ExchangeThe 1,000X Crypto PlaybookTrue Market InsidersUrgent Nvidia WarningAltimetryCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm PressWhy Is Gold On a MASSIVE rally? Huge Alerts